These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35905017)

  • 1. Secondary bacterial infections of the respiratory tract in COVID-19 patients.
    Mumcuoğlu İ; Çağlar H; Erdem D; Aypak A; Gün P; Kurşun Ş; Çakır EY; Aydoğan S; Kırca F; Dinç B
    J Infect Dev Ctries; 2022 Jul; 16(7):1131-1137. PubMed ID: 35905017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etiology and antimicrobial resistance of secondary bacterial infections in patients hospitalized with COVID-19 in Wuhan, China: a retrospective analysis.
    Li J; Wang J; Yang Y; Cai P; Cao J; Cai X; Zhang Y
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):153. PubMed ID: 32962731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020.
    Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C
    Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU.
    Sharifipour E; Shams S; Esmkhani M; Khodadadi J; Fotouhi-Ardakani R; Koohpaei A; Doosti Z; Ej Golzari S
    BMC Infect Dis; 2020 Sep; 20(1):646. PubMed ID: 32873235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.
    Balkhair A; Al-Muharrmi Z; Al'Adawi B; Al Busaidi I; Taher HB; Al-Siyabi T; Al Amin M; Hassan KS
    Int J Infect Dis; 2019 Aug; 85():10-15. PubMed ID: 31100418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Clinical Profiles and Fatality Rates in Hospitalized Patients Reveal Case Aggravation and Selective Co-Infection by Limited Gram-Negative Bacteria.
    Said KB; Alsolami A; Moussa S; Alfouzan F; Bashir AI; Rashidi M; Aborans R; Taha TE; Almansour H; Alazmi M; Al-Otaibi A; Aljaloud L; Al-Anazi B; Mohialdin A; Aljadani A
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary bacterial infections and antimicrobial resistance in COVID-19: comparative evaluation of pre-pandemic and pandemic-era, a retrospective single center study.
    Karataş M; Yaşar-Duman M; Tünger A; Çilli F; Aydemir Ş; Özenci V
    Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):51. PubMed ID: 34353332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology and Multi-Drug Resistant Profile of Bacterial Infections in Severe Burn Patients, Romania 2018-2022.
    Nițescu B; Pițigoi D; Tălăpan D; Nițescu M; Aramă SȘ; Pavel B; Streinu-Cercel A; Rafila A; Aramă V
    Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of concurrent infections with colistin-resistant ESBL-positive Klebsiella pneumoniae and OXA-23-producing Acinetobacter baumannii sensitive to colistin only in a Romanian cardiac intensive care unit.
    Timofte D; Dan M; Maciuca IE; Ciucu L; Dabija ER; Guguianu E; Panzaru CV
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2069-74. PubMed ID: 26239064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary bacterial infections in patients with coronavirus disease 2019-associated pneumonia.
    Aydemir O; Aydemir Y; Şahin EÖ; Şahin F; Koroglu M; Erdem AF
    Rev Assoc Med Bras (1992); 2022 Feb; 68(2):142-146. PubMed ID: 35239872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparative Study on Bacterial Co-Infections and Prevalence of Multidrug Resistant Organisms among Patients in COVID and Non-COVID Intensive Care Units.
    Sathyakamala R; Peace AR; Shanmugam P
    J Prev Med Hyg; 2022 Mar; 63(1):E19-E26. PubMed ID: 35647371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus aureus respiratory tract superinfections among patients with COVID-19 at a tertiary-care hospital in Tehran, Iran.
    Mobarak-Qamsari M; Jenaghi B; Sahebi L; Norouzi-Shadehi M; Salehi MR; Shakoori-Farahani A; Khoshnevis H; Abdollahi A; Feizabadi MM
    Eur J Med Res; 2023 Sep; 28(1):314. PubMed ID: 37660109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiological factors causing lower respiratory tract infections isolated from hospitalized patients.
    Guzek A; Rybicki Z; Korzeniewski K; Mackiewicz K; Saks E; Chciałowski A; Zwolińska E
    Adv Exp Med Biol; 2015; 835():37-44. PubMed ID: 25310945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii.
    Garza-González E; Llaca-Díaz JM; Bosques-Padilla FJ; González GM
    Chemotherapy; 2010; 56(4):275-9. PubMed ID: 20693798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009].
    Hamouche E; Sarkis DK
    Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.
    McCracken M; Mataseje LF; Loo V; Walkty A; Adam HJ; Hoban DJ; Zhanel GG; Mulvey MR;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):335-41. PubMed ID: 21353962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).
    Jean SS; Lee WS; Yu KW; Liao CH; Hsu CW; Chang FY; Ko WC; Chen RJ; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Lam C; Liu CY; Hsueh PR
    J Microbiol Immunol Infect; 2016 Dec; 49(6):969-976. PubMed ID: 25661253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
    Zhang X; Gu B; Mei Y; Wen Y; Xia W
    J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.